Cancer Flashcards
Ctype of epithelium in cervical cancer
s.c.c (most common)
adeno
associations of cervical cancer
Human papilloma virus
when vaccinated against HPV
12-13 yrs
if HPV +ve increased risk of what other cancers
anal
vulval
vaginal
penis
mouth and throat
2 important strains of HPV
type 16 and 18
what tell pt with HPV +VE
no treatment for infection with HPV. Most cases resolve spontaneously within two years, while some will persist.
pathophysiology of HPV causing cervical cancer
P53 and pRb are tumour suppressor genes. They have a role in suppressing cancers from developing. HPV produces two proteins (E6 and E7) that inhibit these tumour suppressor genes. The E6 protein inhibits p53, and the E7 protein inhibits pRb. Therefore, HPV promotes the development of cancer by inhibiting tumour suppressor genes.
risk fx of cervical cancer
Increased risk of catching HPV
Later detection of precancerous and cancerous changes (non-engagement with screening)
Other risk factors
Smoking
HIV (patients with HIV are offered yearly smear tests)
Combined contraceptive pill use for more than five years
Increased number of full-term pregnancies
Family history
Exposure to diethylstilbestrol during fetal development (this was previously used to prevent miscarriages before 1971)
increased risk of catching HPV
Early sexual activity
Increased number of sexual partners
Sexual partners who have had more partners
Not using condoms
presentation of cervical cancer
asx - screening
Abnormal vaginal bleeding (intermenstrual, postcoital or post-menopausal bleeding)
Vaginal discharge
Pelvic pain
Dyspareunia (pain or discomfort with sex)
ix for cervical cancer
examine cervix with speculum and swab
if abnormal - urgent referral for colposcopy
cervical appearance requiring 2WW
Ulceration
Inflammation
Bleeding
Visible tumour
grading system for dysplasia in cervical cancer
CIN
CIN I: mild dysplasia, affecting 1/3 the thickness of the epithelial layer, likely to return to normal without treatment
CIN II: moderate dysplasia, affecting 2/3 the thickness of the epithelial layer, likely to progress to cancer if untreated
CIN III: severe dysplasia, very likely to progress to cancer if untreated/carcinoma in situ
how screening for cervical cancer
The cells are deposited from the brush into a preservation fluid. This fluid is transported to a lab where the cells are examined under a microscope for precancerous changes (dyskaryosis). This way of transporting the cells is called liquid-based cytology.
tested for high risk HPV, if -ve, cells not examined and smear is negative
when attend cervical screening
Every three years aged 25 – 49
Every five years aged 50 – 64
cervical screening additional testing circumstances
Women with HIV are screened annually
Women over 65 may request a smear if they have not had one since aged 50
Women with previous CIN may require additional tests (e.g. test of cure after treatment)
Certain groups of immunocompromised women may have additional screening (e.g. women on dialysis, cytotoxic drugs or undergoing an organ transplant)
Pregnant women due a routine smear should wait until 12 weeks post-partum
infections found on smear
BV
candidiasis
trichomoniasis
IUS infection associated
Actinomyces-like organisms are often discovered in women with an intrauterine device (coil). These do not require treatment unless they are symptomatic. Where the woman is symptomatic (e.g. pelvic pain or abnormal bleeding), removal of the intrauterine device
Summary of mx from smear results
Inadequate sample – repeat the smear after at least three months
HPV negative – continue routine screening
HPV positive with normal cytology – repeat the HPV test after 12 months
HPV positive with abnormal cytology – refer for colposcopy
What is colposcopy
inserting a speculum and using equipment (a colposcope) to magnify the cervix. This allows the epithelial lining of the cervix to be examined in detail. During colposcopy, stains such as acetic acid and iodine solution can be used to differentiate abnormal areas
If abnormal - white with acetate, not stain wirh iodine
How get tissue sample during colposcopy
Punch biopsy
Large loop excision of transformation zone
Large loop excision of the transformation zone how work
Local anaesthetic
using a loop of wire with electrical current (diathermy) to remove abnormal epithelial tissue on the cervix. The electrical current cauterises the tissue and stops bleeding.
S/e - bleeding and abnormal discharge, increases risk of pre term labour
C/i - using tampons or sex after
Cone biopsy how work
Indications - can be used for tx for CIN and very early stage cancer
General anaesthetic
Sent for histology
Risks -Pain
Bleeding
Infection
Scar formation with stenosis of the cervix
Increased risk of miscarriage and premature labour
Staging cervical cancer
FIGO
Stage 1: Confined to the cervix
Stage 2: Invades the uterus or upper 2/3 of the vagina
Stage 3: Invades the pelvic wall or lower 1/3 of the vagina
Stage 4: Invades the bladder, rectum or beyond the pelvis
Mx of cervical cancer
Cervical intraepithelial neoplasia and early-stage 1A: LLETZ or cone biopsy
Stage 1B – 2A: Radical hysterectomy and removal of local lymph nodes with chemotherapy and radiotherapy
Stage 2B – 4A: Chemotherapy and radiotherapy
Stage 4B: Management may involve a combination of surgery, radiotherapy, chemotherapy and palliative care
Survival cervical cancer
The 5-year survival drops significantly with more advanced cervical cancer, from around 98% with stage 1A to around 15% with stage 4.
Mx of advanced cervical cancer
Pelvic exenteration - removing most or all of the pelvic organs, including the vagina, cervix, uterus, fallopian tubes, ovaries, bladder and rectum.
Chemo Tx of cervical cancer
Bevacizumab (avastin) - targets vascular endothelial growth factor A (VEGF-A), which is responsible for the development of new blood vessels. Therefore, it reduces the development of new blood vessels. You may also come across this medication as a treatment for wet age-related macular degeneration
HPV strains causing genital warts
6 and 11